Atlas Trials

Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms)

Clinical trial NCT04576494 · COMPLETED

Trial details

NCT number
NCT04576494
Sponsor
CHU de Reims
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Spinal Muscular Atrophy
Start date
2022-01-24
Primary completion
2023-01-24
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.